ArticleJournal for immunotherapy of cancer2021
High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege.
Casey R Ager et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this papercites it